Encrypgen

EncrypGen's Gene-Chain uses a blockchain to help privately store users' genetic data and associate it with user- supplied metadata such as that collected by genetic testing companies so that users can store and sell their de-identified data directly to researchers in exchange for DNA, a cryptocurrency they can then exchange for money. EncrypGen takes only 10% or less of the price of the sale as a commission (which can be shared with partners).

 

There is no cost for users to upload their data and create a profile, and data buyers buy data with DNA which can also be purchased from us, or on any number of third-party markets. Encrypgen offers an extensible survey system for researches to expand upon user-submitted profiles, allowing the most flexible data-gathering mechanism, anonymized by our blockchain and identified at sale.

In May of 2017, the team demoed a prototype at the Bio-World IT conference in Boston, MA.
We interact directly with customers, without the use of any intermediaries.
As of 2019, we have achieved a user base of about 1100 who have uploaded 767 files that have been purchased 175 times for an average of 15 USD each.
We are founded by a bioethicist/author of Who Owns You? (Dr. Koepsell) who fought for a decade for rights to genetic data, and a practicing genetic scientist, Dr. Vanessa Gonzalez.
We hosted the worlds’ first blockchain-based sale of genetic data in 2018 using our currency, $DNA.

David Koepsell
FOUNDER
CEO & FOUNDER
With a background in law, ethics, tech and having authored numerous books and articles on genes, ownership, and ethics, David brings his interest and expertise together to guide the development of systems to enhance the value of genomic databases, while protecting donors and making them stakeholders.

Monica Sandoval
ADVISOR
CMO
Monica is a high-performance marketing strategist with over 12 years of experience at designing global digital marketing initiatives that accomplish targeted business objectives. She has extensive reputation for managing proposals, creative problem solving, executing contracts, creating innovative media, and maintaining collaborative relationships with interactive agencies and in-house designer’s and developers.

Vanessa Gonzalez
GENOMIC ADVISOR
Vanessa has a decade of experience in genetic science, including research and publications in numerous journals, and currently researches pharmacogenomics, the foundational science behind the nascent field of personal medical genomics.

Dr. Notis Gasparis
PLATFORM DEVELOPMENT ADVISOR
Notis brings over 20 years experience holding several software development positions among many global companies. He holds a BSc in Computer Science, an MSc in Distributed Systems and a PhD in Software Engineering. He has also held positions at the University of Essex and Goldsmiths College.

Annual Interest Rate: 7%

Discount Rate: 20%

Maturity Date: 2 years

Shareholder Voting Rights: None

Shareholder Voting Right Limitations: None